Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians | Zendy

Anurag Markanday | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians

Author(s) -

Anurag Markanday

Publication year - 2015

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofv098

Subject(s) - procalcitonin , medicine , intensive care medicine , erythrocyte sedimentation rate , antibiotics , medline , antimicrobial stewardship , medical prescription , acute phase protein , antibiotic resistance , immunology , inflammation , sepsis , microbiology and biotechnology , pharmacology , political science , law , biology

There is increasing evidence to support the role of various acute phase reactants as an adjunct to clinical judgement in the management of various infections. Procalcitonin is more specific in diagnosing bacterial infections and has a wider role in the management of complex infections. Procalcitonin based antibiotic guidance is helpful in antibiotic management in patients with pneumonia and sepsis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research